v3.26.3
FINANCIAL INCOME, NET
12 Months Ended
Jul. 31, 2026
Financial Income Net  
FINANCIAL INCOME, NET

NOTE 13: FINANCIAL INCOME, NET

 

   2026   2025 
   Year ended July 31, 
   2026   2025 
Interest income  $633,766   $119,958 
Unrealized gain on short-term investments   14,804    56,473 
Interest expense   (29,631)   (36,979)
Foreign exchange loss   (17,478)   (24,941)
Financial income, net  $601,461   $114,511 

 

 

BriaCell Therapeutics Corp

Notes to the Consolidated Financial Statements

For the Years Ended July 31, 2026 and 2025

(Expressed in US Dollars, unless otherwise indicated)